Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Snapshot

Business Description:

Zhejiang Jingxin Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector. ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD. is a China-based company engaged in manufacture and sale of pharmaceuticals. The Company provides raw materials of chemical drugs, chemical preparations and Chinese herbal preparations, including quinolone drugs, drugs for cardio-cerebral-vascular diseases, cephalosporin drugs, traditional Chinese herbal medicines and other drugs. It distributes its products principally in domestic markets. As of December 31, 2010, the Company had five major subsidiaries, which involved in manufacture, sale, import and export trading of pharmaceuticals. In our complete report available for purchase the company is compared to: Hubei Guangji Pharmaceutical Co., Ltd., Hainan Haiyao Company Limited and Henan Lingrui Pharmaceutical Co., Ltd..

Zhejiang Jingxin Pharmaceutical Co., Ltd.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 12.86
(Figures in Chinese Renmimbi)

1 Week	n/a	13 Weeks	-11.4%

4 Weeks	-39.3%	52 Weeks	-24.1%

Zhejiang Jingxin Pharmaceutical Co., Ltd. Key Data:

Ticker:	002020	Country:	CHINA

Exchanges:	SZN	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	631,019,000 (Year Ending Jan 2011).	Employees:	1,242

Currency:	Chinese Renmimbi	Market Cap:	1,305,933,000

Fiscal Yr Ends:	December	Shares Outstanding:	101,550,000

Share Type:	A Shares	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.